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Abstract
Background: The concept of perioperative glycemic control in cardiac surgery patients was conducted in many studies, however, it
remains unclear how tight the glycemic control should be. Our aim is to study the effect of perioperative tight glycemic control
versus moderate glycemic control on the outcome of diabetic patients undergoing coronary artery bypass graft (CABG) surgery.
Methods: This study is a randomized prospective study conducted on 135 diabetic patients planned for CABG surgery. Patients
were divided into 2 groups: group A subjected to tight glycemic control during operation to maintain blood glucose level between
110 and 149 mg/dl and group B subjected to conventional moderate glycemic control to achieve blood glucose level between 150
and 180 mg/dl using continuous insulin infusion started before anesthesia induction and continued till the patient is extubated in
ICU. Both groups were followed up till 1 month after operation regarding operative mortality and postoperative outcome.
Results: No significant difference between both groups in mortality, however there was statistical significant relationship between
tight glycemic control group and lowered incidence of postoperative atrial fibrillation, sternal wound infection, need for inotropic
support and reduced time spent on mechanical ventilation.We noticed reduction in incidence of acute renal failure in tight glycemic
control with no difference between both groups in neurological insults, renal dysfunction and perioperative myocardial infarction.
Conclusion: Tight glycemic control improved perioperative outcome in diabetic CABG patients. Maintaining perioperative blood
glucose level between 110 and 149 mg/dl is safe and should be recommended as a routine practice in diabetic patients undergoing
CABG surgery.
Copyright © 2016, The Egyptian Society of Cardio-thoracic Surgery. Publishing services by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Approximately half of patients candidate for coronary artery bypass graft surgery (CABG surgery) have diabetes
mellitus or metabolic syndrome [1]. Diabetic patients are characterized by more diffuse coronary artery disease,
abnormal fibrinolysis, impaired platelet function, abnormal endothelial function with more expectation of lower graft
patency and increased perioperative mortality [2,3]. Postoperative hyperglycemia was considered as a predictor of
poor outcome post CABG surgery [4]. Uncontrolled hyperglycemia can predispose to increased incidence of ischemic
brain injury, arrhythmia and sternal wound infection due to impaired phagocytosis and neutrophilic function in
diabetic patients [5,6].
The concept of perioperative glycemic control in cardiac surgery patients was conducted in many studies. The
Society of Thoracic Surgeons published guidelines regarding blood glucose management during cardiac surgery,
recommending maintenance of blood glucose <180 mg/dl utilizing an insulin infusion and maintaining the level to
less than 150 mg/dl in high risk cases [7]. While there is consensus that hyperglycemia should be avoided in the
perioperative period in patients undergoing open-heart surgery, it remains unclear how tight the glycemic control
should be.
In this study we aimed to detect the effect of perioperative tight glycemic control versus moderate glycemic control
on the outcome of diabetic patients undergoing CABG surgery.
2. Patients and methods
This study is a randomized prospective study conducted on 135 diabetic patients planned for CABG surgery during
the period from January 2013 till January 2015 in Tanta University Hospital and National Heart Institute. We excluded
from the study emergency CABG, off pump surgery and combined valve and CABG surgery. Patients were randomly
assigned into 2 groups according to computer allocated generation table (graph pad software). Informed consent was
taken from all patients involved in the study. Group A including 67 patients who were subjected to tight glycemic
control during operation to maintain blood glucose level between 110 and 149 mg/dl and group B including 68 pa-
tients who were subjected to conventional moderate glycemic control to achieve blood glucose level between 150 and
180 mg/dl during operation. Perioperative tight glycemic control was achieved by continuous insulin infusion using
insulin actrapid HM Novonordisk 50 unit in 500 ml saline 0.9% by syringe pump started before anesthesia induction
and continued till patient weaned from mechanical ventilation. The blood glucose was checked hourly by blood
glucose meter.
All patients involved in the study were subjected to complete history taking including age, sex, hypertension,
preoperative blood glucose level, COPD, history of myocardial infarction, renal dysfunction and cerebrovascular
accident. Preoperative echocardiography was done to detect ejection fraction, wall motion abnormality (hypokinesia,
dyskinesia or akinesia) and associated valve lesion. Preoperative coronary angiography was examined regarding
number of vessels to be grafted and degree of stenosis of each vessel. All patients in the study were operated on
cardiopulmonary bypass and cold blood cardioplegia were administered to all patients. LIMA were harvested in all
patients and anastomosed to LAD. Saphenous vein grafts were harvested and grafted to other vessels. Cardiopul-
monary bypass time and aortic cross clamp time were recorded in all cases.
Patients in both groups were followed up for operative mortality (defined as mortality within 30 days of
operation or during hospitalization due to cause related to operation), renal dysfunction (elevated serum creatinine
above 2 mg/dl postoperative or more than 25% of preoperative level), acute renal failure required postoperative
dialysis, postoperative permanent neurological deficit, sternal wound infection, leg infection and need for post-
operative inotropic support that was defined as the use of dopamine 5 mg/kg/min; any dose of epinephrine,
norepinephrine, dobutamine, or milrinone. All patients were followed up regarding duration of mechanical
ventilation postoperatively. Prolonged mechanical ventilation was defined as cumulative duration of 24 h or more
of endotracheal intubation starting from transfer of the patient to cardiac surgery ICU after completion of oper-
ation. The occurrence of postoperative atrial fibrillation (AF), and perioperative myocardial infarction were
recorded. Perioperative myocardial infarction was defined as any patient having fresh ECG changes including new
Q-waves in two precordial leads, new bundle branch block, hemodynamic compromise with new segmental wall
motion dysfunction or elevation of CK MB over 100 U/L after undergoing open heart surgery. Patients were
discharged from hospital when they had stable cardiac rhythm, temperature less than 37.5 C, well healed incision,
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visits to hospital or directly by telephone.3. Statistical analysis
Statistical analysis was performed using Statistical Package for Social Science (SPSS version 16). Data were
expressed in terms of frequencies and percentages for categorical variables and mean ± standard deviation (±SD) for
continuous variables. For comparing categorical data, Chi-square (X2) test was performed. When the group was
compared for continuous variable, student's unpaired t test was used. P values of <0.05 were considered statistically
significant.4. Results
One hundred thirty five patients were enrolled in this study. They were divided into 2 groups: group A included 67
patients with tight glycemic control and group B included 68 patients with moderate glycemic control. Preoperative
and operative characters of both groups are shown in Table 1 with no statistical significant difference between both
groups. Forty nine patients (73.13%) of group A and 46 patients (67.65%) of group B were male. The mean age was
54.99 ± 6.49 in group A and 56.40 ± 7.79 in group B. History of myocardial infarction, cerebrovascular accidents and
renal dysfunction were similar in both groups. Preoperative ejection fraction was 56.45 ± 7.37 in group A and
55.32 ± 7.26 in group B. Cardiopulmonary bypass time was 76.37 ± 20.24 min in group A and 86.09 ± 21.71 min in
group B. Aortic cross clamp was 50.93 ± 14.41 min in group A and 49.24 ± 15.85 min in group B.
By comparison between both groups regarding outcome, we had six deaths in our study, 2 (2.99%) in group A and 4
(5.88%) in group B (p value 0.414).
Occurrence of postoperative hypoglycemic events was detected in 3 patients (4.48%) in group A and only one
patient (1.47%) in group B (p value 0.303) indicating safety use of tight glycemic control protocol with no adverse
effects.Table 1
Preoperative and operative patients' characters in both groups.
Tight glycemic control
Group A
Total ¼ 67
n (%)
Moderate glycemic control
Group B
Total ¼ 68
n (%)
P value
Age (mean ± SD) 54.99 ± 6.49 56.40 ± 7.79 0.255
Sex
Male 49 (73.13) 46 (67.65) 0.485
Female 18 (26.87) 22 (32.35)
Hypertension
Yes 54 (80.6) 53 (77.94) 0.703
No 13 (19.4) 15 (22.06)
Preoperative Blood glucose 164.06 ± 12.09 166.90 ± 16.77 0.262
History of renal dysfunction
Yes 5 (7.46) 3 (4.41) 0.453
No 62 (92.54) 65 (95.59)
History of cerebrovascular accident
Yes 3 (4.48) 2 (2.94) 0.637
No 64 (95.52) 66 (97.06)
History of Myocardial infarction
Yes 24 (35.82) 22 (32.35) 0.671
No 43 (64.18) 46 (67.65)
Ejection fraction (mean ± SD) 56.45 ± 7.37 55.32 ± 7.26 0.373
No of vessels to be grafted (mean ± SD) 3.53 ± 1.18 3.48 ± 1.11 0.793
Cardiopulmonary bypass time (mean ± SD) 78.45 ± 21.97 85.38 ± 20.60 0.063
Aortic cross clamp time (mean ± SD) 50.93 ± 14.41 49.24 ± 15.85 0.304
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ference between both groups (P value. 0.025) reflecting the importance of tight glycemic control in reducing post-
operative AF.
There was no significant difference between both groups regarding neurological insults, perioperative myocardial
infarction and postoperative renal dysfunction. However, we found that acute renal failure was more common in
patients with moderate glycemic control.
There was statistical significant difference between both groups regarding prolonged mechanical ventilation,
wound infection and need for inotropic support as shown in Table 2.
5. Discussion
Perioperative blood glucose control and administration of insulin infusion during CABG surgery in diabetic pa-
tients is expected to have beneficial effect on patients' outcome. Administration of insulin will increase glucose uptake
by myocytes, promoting glycogenesis and reducing free fatty acids thus protecting heart against ischemia provided by
cardiopulmonary bypass [8].
Also, hyperglycemia has a pro-inflammatory effect that may contribute to postoperative capillary leak syndrome,
platelet dysfunction and altered immune response that could be avoided by blood glucose control [9].
By revision of studies conducted on the effect of tight glycemic control of diabetic patients on patients' outcome
after CABG surgery, there was no fixed blood glucose range that was taken as single reference in these studies. TheTable 2
Postoperative patients outcome on both groups.
Tight glycemic control
Group A
Total ¼ 67
n (%)
Moderate glycemic control
Group B Total ¼ 68
n (%)
P value
Mortality
Yes 2 (2.99) 4 (5.88) 0.414
No 65 (97.01) 64 (94.12)
Postoperative hypoglycemic events
Yes 3 (4.48) 1 (1.47) 0.303
No 64 (95.52) 67 (98.53)
Postoperative AF
Yes 13 (19.4) 25 (36.76) 0.025a
No 54 (80.6) 43 (63.24)
Perioperative MI
Yes 3 (4.48) 4 (5.88) 0.713
No 64 (95.52) 64 (94.12)
Acute renal failure
Yes 2 (2.99) 8 (11.76) 0.051
No 65 (97.01) 60 (88.24)
Neurological insult
Yes 4 (5.97) 5 (7.35) 0.747
No 63 (94.03) 63 (92.65)
Need for inotropic support
Yes 28 (41.79) 45 (66.18) 0.004a
No 39 (58.21) 23 (33.82)
Prolonged mechanical ventilation
Yes 9 (13.43) 19 (27.94) 0.038a
No 58 (86.57) 49 (72.06)
Sternal wound infection
Yes 14 (20.9) 27 (39.71) 0.012a
No 53 (79.1) 41 (60.29)
Leg wound infection
Yes 13 (19.40) 24 (35.29) 0.038a
No 54 (80.60) 44 (64.71)
a Statistically significant (p value < 0.05).
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now it remains unclear how tight the glycemic control should be. For reasons of safety, in our study, we followed the
recommendation of American Association of Clinical Endocrinologists and American Diabetes Association (ADA/
AACE) to define tight glycemic control to be between 110 and 149 mg/dl and moderate glycemic control to be be-
tween 150 and 180 mg/dl [10].
One of the first trials to achieve tight glycemic control was conducted by van den Berghe et al. and their blood
glucose level target was between 80 and 110 mg/dl [11]. They included critical illness patients specifically cardiac
surgery patients and the results showed much improvement in mortality and morbidity in tight group recommending
using it as a routine practice. Another study by Funrary et al. have demonstrated that glycemic control using insulin
protocols improves operative mortality, lowers operative morbidity, and improves long-term survival [12].
In 2009, Normoglycemia in Intensive Care Evaluation-Survival Using Glucose Algorithm Regulation (NICE-
SUGAR) trial made much change in concept of tight glycemic control as they found that intensive glucose control
(81e108 mg/dl) actually increased 90-day mortality with more episodes of hypoglycemia recommending more liberal
control of blood glucose level [13].
Lazar et al. completed a prospective, randomized trial in diabetic patients undergoing CABG and found that tight
glycemic control (80e110) mg/dl increased the incidence of hypoglycemic events with no significant improvement in
clinical outcomes that was achieved with the more moderate glycemic control between 120 and 180 mg/dl [14]. Desai
et al. found in their study on isolated CABG patients that liberal blood glucose control between 121 and 180 mg/dl has
better outcome in relation to blood glucose control and target range needed and similar outcome to tight glycemic
control regarding morbidity and mortality [15].
More recently Blaha and colleagues found that tight glycemic control has beneficial effect on outcome of non-
diabetic patients with little effect on diabetic patients post cardiac surgery [16].
In our study, we did not find statistical significant difference between both groups regarding mortality. This may be
attributed to low number of patients in our study. This is similar to Gorban et al. and Chan et al. who found no
difference between the two groups (group A with a treated range of 80e130 mg/dl and a control group of
160e200 mg/dl) in various clinical outcomes, including mortality, length of stay, and infection rate [17,18]. Also,
Ingels et al. in their study showed no significant benefit of tight glycemic control over normal control on long term
mortality [19].
In our study, we found relationship between tight glycemic control and reduced incidence of acute renal failure that
required dialysis. This is in accordance to several studies who found that uncontrolled hyperglycemia induced by
cardiopulmonary bypass in cardiac surgery is associated with increased incidence of postoperative renal dialysis and
intraoperative poor glycemic control is associated with seven fold increase in incidence of acute renal failure [20,21].
This could be explained by Han et al. and Baines et al. who demonstrated that hyperglycemia can induce oxidative
stress that inhibits Naþ/glucose cotransporter activity in renal proximal tubule cells and stimulates renal oxygen
consumption by increased endothelial nitric oxide synthase promoting renal dysfunction [22,23].
Regarding wound infection, in our study, we found that tight glycemic control was associated with better outcome
regarding sternal wound infection and leg infection. This is in agreement to results given by Zerre and colleagues in
their retrospective study who found that elevated blood glucose level within 48 h of operation was an independent risk
factor for sternal wound infection [24] and another study by Elassi et al. who found that diabetic patients has good
outcome post CABG surgery except sternal wound infection [25]. The relationship between tight glycemic control and
decreased surgical wound infection was addressed first in 1991 when the American College of Cardiology and
American Heart Association noted increased incidence of wound infection in diabetic patients [26].
Hyperglycemia has been hypothesized to affect leukocyte function by reduction in bactericidal capacity, reduced
phagocytosis, chemotaxis and adherence to bacteria. Also, leukocyte function has an inverse relationship to the extent
of hyperglycemia [27,28]. However one study by Estrada et al. found no statistical significant relationship between
surgical site infection and blood glucose level despite only 35% of patients involved in the study were diabetic [29].
AF following cardiac surgery is common affecting up to 20e30% of patients [30]. The mechanisms by which atrial
fibrillation can occur after cardiac surgery is unclear including poor cooling of atrium, increased sympathetic activity,
and withdrawal of preoperative Beblockers [31e33]. All the previous factors could contribute to change in refractory
period in the atrium predisposing to atrial fibrillation [34]. In our study, we found significant reduction in AF in tight
glycemic control group. This is may be supported by previous study by lazar et al. [14] and could be explained by the
effect of insulin on increased uptake of potassium by myocyte causing sinus rhythm post cardiac surgery. Also, Zhang
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sensitive to insulin [35].
In our study, we found that prolonged mechanical ventilation more than 24 h was more significant in patients with
moderate glycemic control. Prolonged mechanical ventilation may be related to delayed recovery from anesthesia
caused by disruption of blood brain barrier and aggravation of cerebral edema induced by hyperglycemia [36]. Haja
et al. found in meta-analysis on the effect of tight glycemic control on patients morbidity and mortality that there was a
significant reduction in the amount of time spent on ventilation for those patients who had tight glycemic control
compared to controls. However, there was also significant heterogeneity in the data which were heavily weighted by
Lazar study [37].
In our study, there was no statistical significant difference between both groups regarding incidence of hypogly-
cemic events encouraging safety use of tight glycemic control protocol. Recently, there was a study assessing the
effect of hyperinsulinaemic normoglycemia on patient conscious level after cardiac surgery showing that tight gly-
cemia augments the risk of delirium but not its severity post cardiac surgery [38].
5.1. Future perspectives
We believe that there is better overall recovery in tight glycemic control group compared to moderate control. More
research may be needed on large number of patients with comparison of different protocols that can achieve tight
glycemic control regarding accuracy and compliance. Long term follow up of patients can give more information on
the effectiveness of tight glycemic control on graft patency and long term survival rate.
6. Conclusion
From our study we can conclude that tight glycemic control improved perioperative outcome in diabetic CABG
patients with less incidence of surgical wound infection, atrial fibrillation, acute renal failure, need for inotropic
support and time spent on mechanical ventilation. Maintaining perioperative blood glucose level between 110 and
149 mg/dl is safe and should be recommended as a routine practice in diabetic patients undergoing CABG surgery.
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